Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · Real-Time Price · USD

9.64

+0.91 (10.42%)

At close: Jun 2, 2026, 4:00 PM EDT

9.54

-0.10 (-1.04%)

After-hours: Jun 2, 2026, 7:59 PM EDT

Burning Rock Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	539.57	515.82	537.44	563.24	507.86
Revenue Growth (YoY)	4.60%	-4.02%	-4.58%	10.90%	18.13%
Cost of Revenue	136.65	153.42	174.21	183.2	143.72
Gross Profit	402.91	362.4	363.23	380.04	364.15
Selling, General & Admin	-291.27	-452.54	-685.53	-938.58	-793.35
Research & Development	-166.49	-232.29	-347.02	-421.87	-367.86
Other Operating Expenses	-	-35.13	-	-	-
Total Operating Expenses	-457.76	-719.96	-1,033	-1,360	-1,161
Operating Income	-54.85	-357.56	-669.32	-980.41	-797.06
Interest Income	8.05	12.21	17.96	9.36	3.46
Interest Expense	-0.03	-	-	0.1	-1.54
Other Non-Operating Income (Expense)	-6.97	4.61	0.06	1.7	-0.66
Total Non-Operating Income (Expense)	1.06	16.82	18.02	11.16	1.27
Pretax Income	-53.79	-340.74	-651.3	-969.25	-795.8
Provision for Income Taxes	-1.56	-5.89	-2.39	-1.99	-0.9
Net Income	-55.35	-346.63	-653.69	-971.23	-796.7
Net Income to Common	-55.35	-346.63	-653.69	-971.23	-796.7
Shares Outstanding (Basic)	11	11	10	10	11
Shares Outstanding (Diluted)	11	11	10	10	11
Shares Change (YoY)	-2.26%	5.05%	-0.20%	-2.35%	0.31%
EPS (Basic)	-5.20	-33.70	-63.80	-93.50	-76.50
EPS (Diluted)	-5.20	-33.70	-63.80	-93.50	-76.50
Shares Outstanding	10.52	10.76	10.24	10.26	10.51
Free Cash Flow	-33.69	-97.68	-263.89	-527.1	-688.81
Free Cash Flow Per Share	-3.20	-9.08	-25.76	-51.35	-65.53
Gross Margin	74.67%	70.26%	67.59%	67.47%	71.70%
Operating Margin	-10.16%	-69.32%	-124.54%	-174.07%	-156.94%
Profit Margin	-10.26%	-67.20%	-121.63%	-172.44%	-156.87%
FCF Margin	-6.24%	-18.94%	-49.10%	-93.58%	-135.63%
EBITDA	-33.08	-305.36	-535.92	-856.31	-749.3
EBITDA Margin	-6.13%	-59.20%	-99.72%	-152.03%	-147.54%
EBIT	-54.85	-357.56	-669.32	-980.41	-797.06
EBIT Margin	-10.16%	-69.32%	-124.54%	-174.07%	-156.94%
Effective Tax Rate	2.89%	1.73%	0.37%	0.20%	0.11%

SEC Filings: 10-K · 10-Q